EnriqueAlvarezIIIMDPhD

Neurology • Aurora, CO

Neuroimmunology/Multiple Sclerosis

Assistant Professor

Join to view full profile

Dr. Alvarez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alvarez's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2007 - 2010
University of ColoradoInternship, Internal Medicine, 2006 - 2007
University of Colorado School of Medicine Anschutz Medical CampusClass of 2006

Certifications & Licensure

CO State Medical License 2013 - 2025
MO State Medical License 2010 - 2014
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis Start of enrollment: 2020 Sep 11
Active, not recruiting

Publications & Presentations

PubMed

Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications.
Carson M Quinn, Prashanth Rajarajan, Alexander J Gill, Hannah Kopinsky, Andrew B Wolf
Neurology. 2024-12-10
1 citations
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies.
Ahmad Abdelrahman, Enrique Alvarez
Neurologic Clinics. 2024-02-01
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis.
Enrique Alvarez, Lawrence Steinman, Edward J Fox, Hans-Peter Hartung, Peiqing Qian
Frontiers in Neurology. 2024-01-01

Press Mentions

Anti-CD20 HGG Linked to Serious Infection Risk in MSJune 7th, 2024
New Scientific Advisory Board Member Dr. Enrique Alvarez on DMTs, Mobility, and MS ProgressionMarch 19th, 2024
Study: Multiple Sclerosis Blood Antibodies Found to Be Toxic to NeuronsApril 25th, 2023
Join now to see all